The poor prognosis constitutes a significant difficulty for spinal cord injury (SCI) individuals. Although mesenchymal stem cells (MSCs) hold promises as advanced therapy medicinal products (ATMPs) for SCI patients, challenges such as Good Manufacturing Practice-compliant manufacturing, cellular senescence, and limited therapeutic efficacy continue to hinder their clinical translation. Recent advances have identified botanical nanovesicles (BNs) as potent bioactive mediators capable of “priming” MSCs to self-rejuvenate, augment paracrine effect, and establish inflammatory tolerance. In this review, we introduce the physicochemical properties of BNs and systematically explore their synergistic relationship with MSCs in regenerative medicine. By integrating BNs with MSC, BNs-empowered MSCs (Be-MSCs) represent next-generation ATMPs. This innovative strategy addresses the limitations of conventional MSC therapies and offers a scalable, nonimmunogenic solution with significant potential for clinical application in SCI.
Impact Statement
Despite the potential of mesenchymal stem cells (MSCs) as regenerative therapies in spinal cord injury (SCI), challenges such as manufacturing standardization, cellular senescence, suboptimal efficacy, and low survival rate in the injury site impede their clinical translation. Botanical nanovesicles (BNs) serve as potent bioactive mediators, priming MSCs to self-rejuvenate, augment paracrine effect, and bolster inflammatory tolerance. In this review, BN-empowered MSCs (Be-MSCs), a next-generation therapeutic product, was thoroughly discussed in SCI, aiming to bring new hope for SCI patients.
ZhengB, TuszynskiMH. Regulation of axonal regeneration after mammalian spinal cord injury. Nat Rev Mol Cell Biol, 2023; 24(6):396–413; doi: 10.1038/s41580-022-00562-y
2.
ZipserCM, CraggJJ, GuestJD, et al.Cell-based and stem-cell-based treatments for spinal cord injury: Evidence from clinical trials. Lancet Neurol, 2022; 21(7):659–670; doi: 10.1016/S1474-4422(21)00464-6
3.
HalperinW, JensenWA. Ultrastructural changes during growth and embryogenesis in carrot cell cultures. J Ultrastruct Res, 1967; 18(3):428–443; doi: 10.1016/s0022-5320(67)80128-x
4.
RegenteM, Corti-MonzónG, MaldonadoAM, et al.Vesicular fractions of sunflower apoplastic fluids are associated with potential exosome marker proteins. FEBS Lett, 2009; 583(20):3363–3366; doi: 10.1016/j.febslet.2009.09.041
5.
JuS, MuJ, DoklandT, et al.Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Mol Ther, 2013; 21(7):1345–1357; doi: 10.1038/mt.2013.64
6.
DadHA, GuTW, ZhuAQ, et al.Plant exosome-like nanovesicles: Emerging therapeutics and drug delivery nanoplatforms. Mol Ther, 2021; 29(1):13–31; doi: 10.1016/j.ymthe.2020.11.030
7.
FengH, YueY, ZhangY, et al.Plant-derived exosome-like nanoparticles: Emerging nanosystems for enhanced tissue engineering. Int J Nanomedicine, 2024; 19:1189–1204; doi: 10.2147/IJN.S448905
8.
CaoM, DiaoN, CaiX, et al.Plant exosome nanovesicles (PENs): Green delivery platforms. Mater Horiz, 2023; 10(10):3879–3894; doi: 10.1039/d3mh01030a
9.
ChenC, XiaG, ZhangS, et al.OMICS-based approaches for discovering active ingredients and regulating gut microbiota of Actinidia arguta exosome-like nanoparticles. Food Funct, 2024; 15(10):5238–5250; doi: 10.1039/d3fo05783f
10.
KimJ, LiS, ZhangS, et al.Plant-derived exosome-like nanoparticles and their therapeutic activities. Asian J Pharm Sci, 2022; 17(1):53–69; doi: 10.1016/j.ajps.2021.05.006
11.
KabuS, GaoY, KwonBK, et al.Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury. J Control Release, 2015; 219:141–154; doi: 10.1016/j.jconrel.2015.08.060
12.
SchuS, NosovM, O’FlynnL, et al.Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med, 2012; 16(9):2094–2103; doi: 10.1111/j.1582-4934.2011.01509.x
13.
LiP, OuQ, ShiS, et al.Immunomodulatory properties of mesenchymal stem cells/dental stem cells and their therapeutic applications. Cell Mol Immunol, 2023; 20(6):558–569; doi: 10.1038/s41423-023-00998-y
14.
SarsenovaM, KimY, RaziyevaK, et al.Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells. Front Immunol, 2022; 13:1010399; doi: 10.3389/fimmu.2022.1010399
15.
XiaY, ZhuJ, YangR, et al.Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances and future challenges. Front Immunol, 2023; 14:1141601; doi: 10.3389/fimmu.2023.1141601
16.
LiuW, RongY, WangJ, et al.Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. J Neuroinflammation, 2020; 17(1):47; doi: 10.1186/s12974-020-1726-7
17.
Assunção SilvaRC, PintoL, SalgadoAJ. Cell transplantation and secretome based approaches in spinal cord injury regenerative medicine. Med Res Rev, 2022; 42(2):850–896; doi: 10.1002/med.21865
LiH, WangC, HeT, et al.Mitochondrial transfer from bone marrow mesenchymal stem cells to motor neurons in spinal cord injury rats via gap junction. Theranostics, 2019; 9(7):2017–2035; doi: 10.7150/thno.29400
20.
ScholpaNE, SchnellmannRG. Mitochondrial-based therapeutics for the treatment of spinal cord injury: Mitochondrial biogenesis as a potential pharmacological target. J Pharmacol Exp Ther, 2017; 363(3):303–313; doi: 10.1124/jpet.117.244806
21.
MehtaA, PrabhakarM, KumarP, et al.Excitotoxicity: Bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol, 2013; 698(1–3):6–18; doi: 10.1016/j.ejphar.2012.10.032
ZhouT, YuanZ, WengJ, et al.Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol, 2021; 14(1):24; doi: 10.1186/s13045-021-01037-x
24.
BurgerSR. Current regulatory issues in cell and tissue therapy. Cytotherapy, 2003; 5(4):289–298; doi: 10.1080/14653240310002324
25.
Fernández-SantosME, Garcia-ArranzM, AndreuEJ, et al.Optimization of Mesenchymal Stromal Cell (MSC) manufacturing processes for a better therapeutic outcome. Front Immunol, 2022; 13:918565; doi: 10.3389/fimmu.2022.918565
26.
MaCY, ZhaiY, LiCT, et al.Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: Promises, problems and prospects. Med Res Rev, 2024; 44(3):919–938; doi: 10.1002/med.22002
27.
CampisiJ, d’Adda di FagagnaF. Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol, 2007; 8(9):729–740; doi: 10.1038/nrm2233
28.
LucasV, CavadasC, AveleiraCA. Cellular senescence: From mechanisms to current biomarkers and senotherapies. Pharmacol Rev, 2023; 75(4):675–713; doi: 10.1124/pharmrev.122.000622
29.
WangB, HanJ, ElisseeffJH, et al.The senescence-associated secretory phenotype and its physiological and pathological implications. Nat Rev Mol Cell Biol, 2024; 25(12):958–978; doi: 10.1038/s41580-024-00727-x
30.
WattsG. Leonard Hayflick and the limits of ageing. Lancet, 2011; 377(9783):2075; doi: 10.1016/S0140-6736(11)60908-2
31.
KapetanosK, AsimakopoulosD, ChristodoulouN, et al.Chronological age affects MSC senescence in vitro-a systematic review. Int J Mol Sci, 2021; 22(15):7945; doi: 10.3390/ijms22157945
32.
BakerN, BoyetteLB, TuanRS. Characterization of bone marrow-derived mesenchymal stem cells in aging. Bone, 2015; 70:37–47; doi: 10.1016/j.bone.2014.10.014
33.
JiangX, LiW, GeL, et al.Mesenchymal stem cell senescence during aging: From mechanisms to rejuvenation strategies. Aging Dis, 2023; 14(5):1651–1676; doi: 10.14336/AD.2023.0208
34.
StolzingA, JonesE, McGonagleD, et al.Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev, 2008; 129(3):163–173; doi: 10.1016/j.mad.2007.12.002
35.
TokalovSV, GrünerS, SchindlerS, et al.Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. Stem Cells Dev, 2007; 16(3):439–446; doi: 10.1089/scd.2006.0078
36.
TangW, HuoF, LongJ, et al.Cellular senescence in craniofacial tissue regeneration: Inducers, biomarkers, and interventions. Tissue Eng Part B Rev, 2024; 30(1):128–141; doi: 10.1089/ten.TEB.2023.0136
37.
BobkovD, PolyanskayaA, MusorinaA, et al.Replicative senescence in MSCWJ-1 human umbilical cord mesenchymal stem cells is marked by characteristic changes in motility, cytoskeletal organization, and RhoA localization. Mol Biol Rep, 2020; 47(5):3867–3883; doi: 10.1007/s11033-020-05476-6
38.
WongPF, DharmaniM, RamasamyTS. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation. Drug Discov Today, 2023; 28(1):103424; doi: 10.1016/j.drudis.2022.103424
39.
MiclauK, HambrightWS, HuardJ, et al.Cellular expansion of MSCs: Shifting the regenerative potential. Aging Cell, 2023; 22(1):e13759; doi: 10.1111/acel.13759
40.
CharifN, LiYY, TargaL, et al.Aging of bone marrow mesenchymal stromal/stem cells: Implications on autologous regenerative medicine. Biomed Mater Eng, 2017; 28(s1):S57–S63; doi: 10.3233/BME-171624
41.
DelormeB, RingeJ, GallayN, et al.Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood, 2008; 111(5):2631–2635; doi: 10.1182/blood-2007-07-099622
42.
GeisslerS, TextorM, KühnischJ, et al.Functional comparison of chronological and in vitro aging: Differential role of the cytoskeleton and mitochondria in mesenchymal stromal cells. PLoS One, 2012; 7(12):e52700; doi: 10.1371/journal.pone.0052700
43.
SiennickaK, ZołocińskaA, DębskiT, et al.Comparison of the donor age-dependent and in vitro culture-dependent mesenchymal stem cell aging in rat model. Stem Cells Int, 2021; 2021:6665358; doi: 10.1155/2021/6665358
44.
RastaldoR, VitaleE, GiachinoC. Dual role of autophagy in regulation of mesenchymal stem cell senescence. Front Cell Dev Biol, 2020; 8:276; doi: 10.3389/fcell.2020.00276
45.
LiuW, LiL, RongY, et al.Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater, 2020; 103:196–212; doi: 10.1016/j.actbio.2019.12.020
46.
ZhiduS, YingT, RuiJ, et al.Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: Challenges and opportunities. Stem Cell Res Ther, 2024; 15(1):266; doi: 10.1186/s13287-024-03885-z
47.
LindsaySL, McCanneyGA, WillisonAG, et al.Multi-target approaches to CNS repair: Olfactory mucosa-derived cells and heparan sulfates. Nat Rev Neurol, 2020; 16(4):229–240; doi: 10.1038/s41582-020-0311-0
48.
YousefifardM, NasirinezhadF, Shardi ManahejiH, et al.Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. Stem Cell Res Ther, 2016; 7:36; doi: 10.1186/s13287-016-0295-2
49.
ShirinM, AgharezaeeiM, AlizadehS, et al.A comparative study of the bone marrow- and umbilical cord-derived Mesenchymal Stem Cells (MSCs) Efficiency on generating MSC-Educated Macrophages (MEMs). Asian Pac J Cancer Prev, 2022; 23(9):3083–3092; doi: 10.31557/APJCP.2022.23.9.3083
50.
LiX, BaiJ, JiX, et al.Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med, 2014; 34(3):695–704; doi: 10.3892/ijmm.2014.1821
51.
PangSHM, D’RozarioJ, MendoncaS, et al.Mesenchymal stromal cell apoptosis is required for their therapeutic function. Nat Commun, 2021; 12(1):6495; doi: 10.1038/s41467-021-26834-3
52.
GalleuA, Riffo-VasquezY, TrentoC, et al.Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation. Sci Transl Med, 2017; 9(416):eaam7828; doi: 10.1126/scitranslmed.aam7828
53.
TrigoCM, RodriguesJS, CamõesSP, et al.Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? J Adv Res, 2025; 70:103–124; doi: 10.1016/j.jare.2024.05.004
54.
BurdickJA, MauckRL, GerechtS. To serve and protect: Hydrogels to improve stem cell-based therapies. Cell Stem Cell, 2016; 18(1):13–15; doi: 10.1016/j.stem.2015.12.004
55.
YinZ, WanB, GongG, et al.ROS: Executioner of regulating cell death in spinal cord injury. Front Immunol, 2024; 15:1330678; doi: 10.3389/fimmu.2024.1330678
56.
DenuRA, HemattiP. Optimization of oxidative stress for mesenchymal stromal/stem cell engraftment, function and longevity. Free Radic Biol Med, 2021; 167:193–200; doi: 10.1016/j.freeradbiomed.2021.02.042
57.
de WitteSFH, LukF, Sierra ParragaJM, et al.Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells. Stem Cells, 2018; 36(4):602–615; doi: 10.1002/stem.2779
58.
GavinC, MeinkeS, HeldringN, et al.The complement system is essential for the phagocytosis of mesenchymal stromal cells by monocytes. Front Immunol, 2019; 10:2249; doi: 10.3389/fimmu.2019.02249
59.
LaurilaJP, LaatikainenL, CastelloneMD, et al.Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy, 2009; 11(6):726–737; doi: 10.3109/14653240903067299
60.
LevitRD, LandázuriN, PhelpsEA, et al.Cellular encapsulation enhances cardiac repair. J Am Heart Assoc, 2013; 2(5):e000367; doi: 10.1161/JAHA.113.000367
OcanseyDKW, PeiB, YanY, et al.Improved therapeutics of modified mesenchymal stem cells: An update. J Transl Med, 2020; 18(1):42; doi: 10.1186/s12967-020-02234-x
63.
LeeMW, RyuS, KimDS, et al.Strategies to improve the immunosuppressive properties of human mesenchymal stem cells. Stem Cell Res Ther, 2015; 6:179; doi: 10.1186/s13287-015-0178-y
64.
YuS, YuS, LiuH, et al.Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases. Stem Cell Res Ther, 2023; 14(1):235; doi: 10.1186/s13287-023-03476-4
65.
YangLY, LiCQ, ZhangYL, et al.Emerging drug delivery vectors: Engineering of plant-derived nanovesicles and their applications in biomedicine. Int J Nanomedicine, 2024; 19:2591–2610; doi: 10.2147/IJN.S454794
66.
JungD, KimNE, KimS, et al.Plant-derived nanovesicles and therapeutic application. Pharmacol Ther, 2025; 269:108832; doi: 10.1016/j.pharmthera.2025.108832
67.
LiuY, RenC, ZhanR, et al.Exploring the potential of plant-derived exosome-like nanovesicle as functional food components for human health: A review. Foods, 2024; 13(5):712; doi: 10.3390/foods13050712
68.
WangY, WuY, ShenS, et al.Engineered plant extracellular vesicles for natural delivery across physiological barriers. Food Funct, 2024; 15(4):1737–1757; doi: 10.1039/d3fo03503d
69.
OreficeNS, Di RaimoR, MizzoniD, et al.Purposing plant-derived exosomes-like nanovesicles for drug delivery: Patents and literature review. Expert Opin Ther Pat, 2023; 33(2):89–100; doi: 10.1080/13543776.2023.2195093
70.
YangC, ZhangM, MerlinD. Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines. J Mater Chem B, 2018; 6(9):1312–1321; doi: 10.1039/C7TB03207B
LiuG, LiX, YangF, et al.C-phycocyanin ameliorates the senescence of mesenchymal stem cells through ZDHHC5-mediated autophagy via PI3K/AKT/mTOR pathway. Aging Dis, 2023; 14(4):1425–1440; doi: 10.14336/AD.2023.0121
73.
JinZ, NaJ, LinX, et al.Plant-derived exosome-like nanovesicles: A novel nanotool for disease therapy. Heliyon, 2024; 10(9):e30630; doi: 10.1016/j.heliyon.2024.e30630
74.
XuXH, YuanTJ, DadHA, et al.Plant exosomes as novel nanoplatforms for microRNA transfer stimulate neural differentiation of stem cells in vitro and in vivo. Nano Lett, 2021; 21(19):8151–8159; doi: 10.1021/acs.nanolett.1c02530
75.
ZhangY, ZhangX, KaiT, et al.Lycium ruthenicum Murray derived exosome-like nanovesicles inhibit Aβ-induced apoptosis in PC12 cells via MAPK and PI3K/AKT signaling pathways. Int J Biol Macromol, 2024; 277(Pt 2):134309; doi: 10.1016/j.ijbiomac.2024.134309
76.
KehmR, BaldenspergerT, RaupbachJ, et al.Protein oxidation-Formation mechanisms, detection and relevance as biomarkers in human diseases. Redox Biol, 2021; 42:101901; doi: 10.1016/j.redox.2021.101901
77.
GaoH, NepovimovaE, HegerZ, et al.Role of hypoxia in cellular senescence. Pharmacol Res, 2023; 194:106841; doi: 10.1016/j.phrs.2023.106841
78.
ZhengX, GongM, ZhangQ, et al.Metabolism and regulation of ascorbic acid in fruits. Plants (Basel), 2022; 11(12):1602; doi: 10.3390/plants11121602
79.
SatoA, KondoY, IshigamiA. The evidence to date: Implications of l-ascorbic acid in the pathophysiology of aging. J Physiol Sci, 2024; 74(1):29; doi: 10.1186/s12576-024-00922-7
80.
LykkesfeldtJ, Tveden-NyborgP. The pharmacokinetics of vitamin C. Nutrients, 2019; 11(10):2412; doi: 10.3390/nu11102412
81.
CastelliG, LogozziM, MizzoniD, et al.Ex vivo anti-leukemic effect of exosome-like grapefruit-derived nanovesicles from organic farming-the potential role of ascorbic acid. Int J Mol Sci, 2023; 24(21):15663; doi: 10.3390/ijms242115663
82.
PerutF, RoncuzziL, AvnetS, et al.Strawberry-derived exosome-like nanoparticles prevent oxidative stress in human mesenchymal stromal cells. Biomolecules, 2021; 11(1):87; doi: 10.3390/biom11010087
83.
MumtazS, AliS, TahirHM, et al.Aging and its treatment with vitamin C: A comprehensive mechanistic review. Mol Biol Rep, 2021; 48(12):8141–8153; doi: 10.1007/s11033-021-06781-4
84.
LiY, WangY, ZhaoH, et al.Engineering strategies of plant-derived exosome-like nanovesicles: Current knowledge and future perspectives. Int J Nanomedicine, 2024; 19:12793–12815; doi: 10.2147/IJN.S496664
85.
ZhaoJ, YuJ, ZhiQ, et al.Anti-aging effects of the fermented anthocyanin extracts of purple sweet potato on Caenorhabditis elegans. Food Funct, 2021; 12(24):12647–12658; doi: 10.1039/d1fo02671b
86.
ZhaoH, LiJ, ZhangJ, et al.Purification, in vitro antioxidant and in vivo anti-aging activities of exopolysaccharides by Agrocybe cylindracea. Int J Biol Macromol, 2017; 102:351–357; doi: 10.1016/j.ijbiomac.2017.04.039
87.
LiN, LiangY, ZhangL, et al.Neolignans in Magnolia officinalis as natural anti-Alzheimer’s disease agents: A systematic review. Ageing Res Rev, 2024; 99:102398; doi: 10.1016/j.arr.2024.102398
88.
TianT, KoCN, LuoW, et al.The anti-aging mechanism of ginsenosides with medicine and food homology. Food Funct, 2023; 14(20):9123–9136; doi: 10.1039/d3fo02580b
89.
SuwanmaneeG, TantrawatpanC, KheolamaiP, et al.Fucoxanthin diminishes oxidative stress damage in human placenta-derived mesenchymal stem cells through the PI3K/Akt/Nrf-2 pathway. Sci Rep, 2023; 13(1):22974; doi: 10.1038/s41598-023-49751-5
90.
ZareF, Ghafouri-FardS, ShamosiA, et al.Oleoylethanolamide protects mesenchymal stem/stromal cells (MSCs) from oxidative stress and reduces adipogenic related genes expression in adipose-derived MSCs undergoing adipocyte differentiation. Mol Biol Rep, 2023; 51(1):33; doi: 10.1007/s11033-023-08929-w
91.
LiW, HuangY, FanL, et al.Curcumin liposomes alleviate senescence of bone marrow mesenchymal stem cells by activating mitophagy. Sci Rep, 2024; 14(1):31291; doi: 10.1038/s41598-024-82614-1
92.
YuQ, ZhangL, WangZ, et al.Anti-inflammatory oligosaccharide licensed mesenchymal stem cells allow prolonged survival of septic rats via the promotion of glutathione synthesis. Phytomedicine, 2024; 135:156173; doi: 10.1016/j.phymed.2024.156173
93.
YuQ, LiaoM, SunC, et al.LBO-EMSC hydrogel serves a dual function in spinal cord injury restoration via the PI3K-Akt-mTOR pathway. ACS Appl Mater Interfaces, 2021; 13(41):48365–48377; doi: 10.1021/acsami.1c12013
94.
WangQ, LiuK, CaoX, et al.Plant-derived exosomes extracted from Lycium barbarum L. loaded with isoliquiritigenin to promote spinal cord injury repair based on 3D printed bionic scaffold. Bioeng Transl Med, 2024; 9(4):e10646; doi: 10.1002/btm2.10646
95.
KrupaP, SvobodovaB, DubisovaJ, et al.Nano-formulated curcumin (Lipodisq™) modulates the local inflammatory response, reduces glial scar and preserves the white matter after spinal cord injury in rats. Neuropharmacology, 2019; 155:54–64; doi: 10.1016/j.neuropharm.2019.05.018
96.
TanZ, XiaoL, MaJ, et al.Integrating hydrogels manipulate ECM deposition after spinal cord injury for specific neural reconnections via neuronal relays. Sci Adv, 2024; 10(27):eado9120; doi: 10.1126/sciadv.ado9120
97.
YaoM, YangL, WangJ, et al.Neurological recovery and antioxidant effects of curcumin for spinal cord injury in the rat: A network meta-analysis and systematic review. J Neurotrauma, 2015; 32(6):381–391; doi: 10.1089/neu.2014.3520
98.
YousefiF, Lavi ArabF, JaafariMR, et al.Immunoregulatory, proliferative and anti-oxidant effects of nanocurcuminoids on adipose-derived mesenchymal stem cells. EXCLI J, 2019; 18:405–421; doi: 10.17179/excli2019-1366
99.
GeW, JiangJ, ArpJ, et al.Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation, 2010; 90(12):1312–1320; doi: 10.1097/TP.0b013e3181fed001
100.
YangQ, LeongSA, ChanKP, et al.Complex effect of continuous curcumin exposure on human bone marrow-derived mesenchymal stem cell regenerative properties through matrix metalloproteinase regulation. Basic Clin Pharmacol Toxicol, 2021; 128(1):141–153; doi: 10.1111/bcpt.13477
101.
ZhouY, GongJ, DengX, et al.Curcumin and nanodelivery systems: New directions for targeted therapy and diagnosis of breast cancer. Biomed Pharmacother, 2024; 180:117404; doi: 10.1016/j.biopha.2024.117404
102.
ZhaoW, ZengM, LiK, et al.Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: Formulation, release in vitro and pharmacokinetics in vivo. Pharm Biol, 2022; 60(1):2300–2307; doi: 10.1080/13880209.2022.2136205
103.
TangC, JinY, WuM, et al.A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal cord injury therapy. Mater Today Bio, 2024; 28:101218; doi: 10.1016/j.mtbio.2024.101218
104.
LenerT, GimonaM, AignerL, et al.Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles, 2015; 4:30087; doi: 10.3402/jev.v4.30087
105.
LiuC, YanX, ZhangY, et al.Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy. J Nanobiotechnology, 2022; 20(1):206; doi: 10.1186/s12951-022-01421-w
106.
ChenX, JiS, YanY, et al.Engineered plant-derived nanovesicles facilitate tumor therapy: Natural bioactivity plus drug controlled release platform. Int J Nanomedicine, 2023; 18:4779–4804; doi: 10.2147/IJN.S413831
107.
MaT, WuJ, MuJ, et al.Biomaterials reinforced MSCs transplantation for spinal cord injury repair. Asian J Pharm Sci, 2022; 17(1):4–19; doi: 10.1016/j.ajps.2021.03.003
108.
LuoG, WosinskiP, Salazar-NorattoGE, et al.Glucose metabolism: Optimizing regenerative functionalities of mesenchymal stromal cells postimplantation. Tissue Eng Part B Rev, 2023; 29(1):47–61; doi: 10.1089/ten.TEB.2022.0063
109.
MuB, ZengY, LuoL, et al.Oxidative stress-mediated protein sulfenylation in human diseases: Past, present, and future. Redox Biol, 2024; 76:103332; doi: 10.1016/j.redox.2024.103332
ZhangJ, LiY, XiongJ, et al.Delivery of pOXR1 through an injectable liposomal nanoparticle enhances spinal cord injury regeneration by alleviating oxidative stress. Bioact Mater, 2021; 6(10):3177–3191; doi: 10.1016/j.bioactmat.2021.03.001
112.
BhoopalanSV, YenJS, LevineRM, et al.Editing human hematopoietic stem cells: Advances and challenges. Cytotherapy, 2023; 25(3):261–269; doi: 10.1016/j.jcyt.2022.08.003
113.
TongS, MoyoB, LeeCM, et al.Engineered materials for in vivo delivery of genome-editing machinery. Nat Rev Mater, 2019; 4:726–737; doi: 10.1038/s41578-019-0145-9
114.
CaiH, HanXJ, LuoZR, et al.Pretreatment with Notoginsenoside R1 enhances the efficacy of neonatal rat mesenchymal stem cell transplantation in model of myocardial infarction through regulating PI3K/Akt/FoxO1 signaling pathways. Stem Cell Res Ther, 2024; 15(1):419; doi: 10.1186/s13287-024-04039-x
115.
KimJY, LeeJS, HanYS, et al.Pretreatment with lycopene attenuates oxidative stress-induced apoptosis in human mesenchymal stem cells. Biomol Ther (Seoul), 2015; 23(6):517–524; doi: 10.4062/biomolther.2015.085
116.
HanYS, LeeJH, JungJS, et al.Fucoidan protects mesenchymal stem cells against oxidative stress and enhances vascular regeneration in a murine hindlimb ischemia model. Int J Cardiol, 2015; 198:187–195; doi: 10.1016/j.ijcard.2015.06.070
117.
HuangD, YinL, LiuX, et al.Geraniin protects bone marrow-derived mesenchymal stem cells against hydrogen peroxide-induced cellular oxidative stress in vitro. Int J Mol Med, 2018; 41(2):739–748; doi: 10.3892/ijmm.2017.3276
118.
ShiDW, ZhangJ, JiangHN, et al.LPS pretreatment ameliorates multiple organ injuries and improves survival in a murine model of polymicrobial sepsis. Inflamm Res, 2011; 60(9):841–849; doi: 10.1007/s00011-011-0342-5
119.
CharoensaensukV, HuangBR, HuangST, et al.LPS priming-induced immune tolerance mitigates LPS-stimulated microglial activation and social avoidance behaviors in mice. J Pharmacol Sci, 2024; 154(4):225–235; doi: 10.1016/j.jphs.2024.02.006
120.
SaeediP, HalabianR, FooladiAAI. Antimicrobial effects of mesenchymal stem cells primed by modified LPS on bacterial clearance in sepsis. J Cell Physiol, 2019; 234(4):4970–4986; doi: 10.1002/jcp.27298
121.
WangXR, JiangZB, XuC, et al.Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response. Pharmacol Res, 2022; 179:106198; doi: 10.1016/j.phrs.2022.106198
122.
Alipanah-MoghadamR, KhodaeiM, AghamohammadiV, et al.Andrographolide induced heme oxygenase-1 expression in MSC-like cells isolated from rat bone marrow exposed to environmental stress. Biochem Biophys Res Commun, 2023; 687:149212; doi: 10.1016/j.bbrc.2023.149212
123.
LuX, XuZ, ShuF, et al.Reactive oxygen species responsive multifunctional fusion extracellular nanovesicles: Prospective treatments for acute heart transplant rejection. Adv Mater, 2024; 36(35):e2406758; doi: 10.1002/adma.202406758
